Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Feb;47(2):113–116. doi: 10.1136/jcp.47.2.113

Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.

C J Bailey 1, R M Hembry 1, A Alexander 1, M H Irving 1, M E Grant 1, C A Shuttleworth 1
PMCID: PMC501822  PMID: 8132824

Abstract

AIMS--To investigate the role of the matrix metalloproteinases (MMPs) in the connective tissue changes seen in the intestine in Crohn's disease. METHODS--Indirect immunofluorescence microscopy using specific antibodies to the MMPs (collagenase, gelatinase A and B, and stromelysin) were used to assess the distribution of these enzymes in normal and diseased intestine. RESULTS--In normal intestine the matrix metalloproteinases were confined to a few isolated inflammatory cells, but in Crohn's disease, the inflammatory infiltrate was associated with increased numbers of polymorphonuclear leucocytes which stained positive for gelatinase B. Stromelysin was also detected extracellularly on the connective tissue matrix in regions of smooth muscle cell proliferation and mucosal degradation. Interestingly, in ulcerative colitis, another inflammatory bowel disease, stromelysin was localised in the lamina propria in regions of mucosal loss. CONCLUSIONS--The increased numbers of inflammatory cells containing gelatinase B, and the localisation of extracellular stromelysin in regions of fibrosis and mucosal degradation, suggest that these enzymes have a role in the pathological changes seen in Crohn's disease. In cases of ulcerative colitis stromelysin was also detected on the lamina propria in regions of mucosal loss, and seems to be associated with the connective tissue changes that precede mucosal loss.

Full text

PDF
113

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. A., Hembry R. M., Angal S., Reynolds J. J., Murphy G. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci. 1991 Aug;99(Pt 4):789–795. doi: 10.1242/jcs.99.4.789. [DOI] [PubMed] [Google Scholar]
  2. Chowcat N. L., Savage F. J., Hembry R. M., Boulos P. B. Role of collagenase in colonic anastomoses: a reappraisal. Br J Surg. 1988 Apr;75(4):330–334. doi: 10.1002/bjs.1800750412. [DOI] [PubMed] [Google Scholar]
  3. Docherty A. J., Murphy G. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis. 1990 Jun;49 (Suppl 1):469–479. [PubMed] [Google Scholar]
  4. Fields G. B., Van Wart H. E., Birkedal-Hansen H. Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. J Biol Chem. 1987 May 5;262(13):6221–6226. [PubMed] [Google Scholar]
  5. Galloway W. A., Murphy G., Sandy J. D., Gavrilovic J., Cawston T. E., Reynolds J. J. Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J. 1983 Mar 1;209(3):741–752. doi: 10.1042/bj2090741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hembry R. M., Murphy G., Reynolds J. J. Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci. 1985 Feb;73:105–119. doi: 10.1242/jcs.73.1.105. [DOI] [PubMed] [Google Scholar]
  7. Hipps D. S., Hembry R. M., Docherty A. J., Reynolds J. J., Murphy G. Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler. 1991 Apr;372(4):287–296. doi: 10.1515/bchm3.1991.372.1.287. [DOI] [PubMed] [Google Scholar]
  8. Matrisian L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990 Apr;6(4):121–125. doi: 10.1016/0168-9525(90)90126-q. [DOI] [PubMed] [Google Scholar]
  9. McDonnell S., Matrisian L. M. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev. 1990 Dec;9(4):305–319. doi: 10.1007/BF00049521. [DOI] [PubMed] [Google Scholar]
  10. Murphy G., Cawston T. E., Galloway W. A., Barnes M. J., Bunning R. A., Mercer E., Reynolds J. J., Burgeson R. E. Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J. 1981 Dec 1;199(3):807–811. doi: 10.1042/bj1990807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murphy G., Cockett M. I., Ward R. V., Docherty A. J. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991 Jul 1;277(Pt 1):277–279. doi: 10.1042/bj2770277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy G., Ward R., Hembry R. M., Reynolds J. J., Kühn K., Tryggvason K. Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J. 1989 Mar 1;258(2):463–472. doi: 10.1042/bj2580463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stetler-Stevenson W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 1990 Dec;9(4):289–303. doi: 10.1007/BF00049520. [DOI] [PubMed] [Google Scholar]
  14. Whitham S. E., Murphy G., Angel P., Rahmsdorf H. J., Smith B. J., Lyons A., Harris T. J., Reynolds J. J., Herrlich P., Docherty A. J. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J. 1986 Dec 15;240(3):913–916. doi: 10.1042/bj2400913. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES